Renal effects of TAPP, a highly selective μ-opioid agonist

British Journal of Pharmacology

Volumn 119, Issue 2, 1996, Pages 239-244

  Gutkowska, Jolanta ^a   Schiller, Peter W ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

ANF; Cyclic GMP; Diuresis; Hypotension; Kaliuresis; Natriuresis; Opioid receptors; Opioids; opioid agonists

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; MU OPIATE RECEPTOR; NALOXONE; OPIATE AGONIST; OPIATE ANTAGONIST; POTASSIUM; SODIUM; TETRAPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG ANTAGONISM; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; KALIURESIS; NATRIURESIS; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL; URINE VOLUME;

EID: 0029835643     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15977.x     Document Type: Article

References (46)

1. ATIONU, A., HASSALL, C., MOULES, E., PATTON, M., SINGER, D.R., BURNSTOCK, G. & CARTER, N.D. (1994). Secretion of atrial and brain natriuretic peptides from human cardiac atrial explants in culture: effect of dynorphin. Cardioscience, 5, 81-85.
2. ATWEH, S.F. & KUHAR, M.J. (1983). Autoradiographic localization of opiate receptors in rat brain. II. The brain stem. Brain Res., 129, 1-12.
3. BALLERMANN, B.J. & BRENNER, B.M. (1985). Biologically active atrial peptides. J. Clin. Invest., 76, 2041-2048.
4. BORGES, F., ANDERSON, J.V., VOLTA, C., PERRY, L., DRURY, P.L., BLOOM, S.R., BESSER, G.M. & GROSSMAN, A. (1988). Opioid peptides do not modulate atrial natriuretic peptide or aldosterone release under basal conditions in man. J. Endocrinol., 116, 313-317.
5. BORST, J.C.C. & BORST-DE GEUS, A. (1983). Hypertension explained by Starling's theory of circulatory homeostasis. Lancet, i, 677-682.
6. CHAVKIN, C. & GOLDSTEIN, A. (1981). Specific receptor for the opiate peptide dynorphin: structure-activity relationships. Proc. Natl. Acad. Sci. U.S.A., 78, 6543-6547.
7. CHEN, M., LEE, J., HUANG, B.S., GREKIN, R.J. & MALVIN, R.L. (1989). Clonidine and morphine increase atrial natriuretic peptide secretion in anesthetized rats. Proc. Soc. Exp. Biol. Med., 191, 299-303.
8. CRUM, R.L. & BROWN, M.R. (1988). Effects of morphine and opioid peptides on plasma levels of atrial natriuretic peptide. Life Sci., 43, 851-858.
9. DE BOLD, A.J., BORENSTEIN, H.B., VERESS, A.T. & SONNENBERG, H. (1981). A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci., 28, 89-94.
10. DE WARDENER, H.E. & MACGREGOR, G.A. (1980). Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int., 18, 1-9.
11. FADEN, A.I. & FEUERSTEIN, G. (1983). Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors. Br. J. Pharmacol., 79, 997-1002.
12. FERRARI, R. & AGNOLETTI, G. (1989). Atrial natriuretic peptide: its mechanism of release from the atrium. Int. J. Cardiol., 24, 137-149.
13. FEUERSTEIN, G. & FADEN, A.I. (1982). Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat. Life Sci., 31, 2197-2200.
14. FONTANA, F., BERNARDI, P., MERLO, P.E., CAPELLI, M., BORTOLUZZI, L., SPAMPINATO, S. & AL. (1993). Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with acute congestive heart failure. Eur. Heart J., 14, 219-225.
15. FONTANA, F., BERNARDI, P., MERLO, P.E., BOSCHI, S., DE IASIO, R., CAPELLI, M., CARBONI, L. & SPAMPINATO, S. (1994). Endogenous opioid system and atrial natriuretic factor in normotensive offspring of hypertensive parents at rest and during exercise test. J. Hypertension, 12, 1285-1290.
16. GARCIA, R., LACHANCE, D., THIBAULT, G., CANTIN, M. & GUTKOWSKA, J. (1986). Mechanism of release of atrial natriuretic factor. Effect of chronic administration of alpha and beta adrenergic and cholinergic agonists on plasma and atrial ANF in the rat. Biochem. Biophys. Res. Commun., 136, 510-520.
17. GUTKOWSKA, J. (1987). Radioimmunoassay for atrial natriuretic factors. Nucl. Med. Biol., 14, 323-331.
18. GUTKOWSKA, J. & NEMER, M. (1989). Structure, expression, and function of atrial natriuretic factor in extraatrial tissues. Endocr. Rev., 10, 519-536.
19. GUTKOWSKA, J., RACZ, K., GARCIA, R., THIBAULT, G., KUCHEL, O., GENEST, J. & CANTIN, M. (1986). The morphine effect on plasma ANF. Eur. J. Pharmacol., 131, 91-94.
20. GUTKOWSKA, J., STRICK, D.M., PAN, L. & MCCANN, S.M. (1993). Effect of morphine on urine output: possible role of atrial natriuretic factor. Eur. J. Pharmacol., 242, 7-13.
21. GUYTON, A.C., COLEMAN, Y.G., COWLEY Jr, A.W., SCHEEL, K.W., MANNING Jr, R.D. & NORMAN Jr, R.A. (1972). Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am. J. Med., 52, 582-589.
22. HAMET, P., PANG, S.C. & TREMBLAY, J. (1989). Atrial natriuretic factor-induced egression of cyclic guanosine 3′:5′-monophosphate in cultured vascular smooth muscle and endothelial cells. J. Biol. Chem., 264, 12364-12369.
23. HASSEN, A.H., FEUERSTEIN, G. & FADEN, A.I. (1982a). Delta versus mu receptors: cardiovascular and respiratory effects of opiate agonists microinjected into nucleus tractus solitarius of rats. Regul. Pept., 4, 299-309.
24. HASSEN, A.H., FEUERSTEIN, G. & FADEN, A.I. (1982b). Mu receptors and opioid cardiovascular effects in the NTS of rat. Peptides, 3, 1031-1037.
25. HOLADAY, J.H. (1983). Cardiovascular effects of endogenous opiate system. Annu. Rev. Pharmacol. Toxicol., 23, 541-594.
26. HORKY, K., GUTKOWSKA, J., GARCIA, R., THIBAULT, G., GENEST, J. & CANTIN, M. (1985). Effect of different anesthetics on immunoreactive atrial natriuretic factor concentration in rat plasma. Biochem. Biophys. Res. Commun., 129, 651-657.
27. HUGHES, J., SMITH, T.W., KOSTERLITZ, H.W., FOTHERGILL, M.A., MORGAN, B.A. & MORRIS, H.R. (1975). Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, 285, 577-579.
28. JOHANNESSON, T. & WOOD, L.A. (1964). Analgesic action and brain and plasma levels of morphine and codeine in morphine tolerant, codeine tolerant and non-tolerant rats. Acta Pharmacol. Kobenhavn, 21, 381-396.
29. KATSUBE, N., SCHWARTZ, D. & NEEDLEMAN, P. (1985). Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure. Biochem. Biophys. Res. Commun., 133, 937-944.
30. KIDD, J.E., NIGEL, L., GILCHRIST, R., UTLEY, J., NICHOLLS, M.G., ESPINER, E.A. & YANDLE, T.G. (1987). Effect of opiate, general anesthesia and surgery on plasma atrial natriuretic peptide levels in man. Clin. Exp. Pharmacol. Physiol., 14, 755-760.
31. KUNOS, G., KARSANG, C. & RAMIREZ-GONZALES, M.D. (1981). β-endorphin: possible involvement in the antihypertensive effect of central α-receptor activation. Science, 211, 82-84.
32. LOUISY, F., GUEZENNEC, C.Y., LARTIGUE, M., ALDIGIER, J.C. & GALEN, F.X. (1989). Influence of endogenous opioids on atrial natriuretic factor release during exercise in man. Eur. J. Appl. Physiol., 59, 34-38.
33. MAACK, T., CAMARGO, M.J.F., KLEINERT, H.D., LARAGH, J.H. & ATLAS, S.A. (1985). Atrial natriuretic factor: structure and functional properties. Kidney Int., 27, 607-615.
34. MANNING, P.T., SCHWARTZ, D., KATSUBE, N.C., HOLMBERG, S.W. & NEEDLEMAN, P. (1985). Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science, 26, 395-397.
35. MILLER, J.W. & ELLIOTT, H.W. (1955). Rat tissue levels of carbon-14 labeled analgesics as related to pharmacological activity. J. Pharmacol. Exp. Ther., 113, 283-291.
36. ÖGUTMAN, C., ÖZBEN, T., SADAN, G., TRAKYA, A. & ISBIR, M. (1990). Morphine increases plasma immunoreactive atrial natriuretic peptide levels in humans. Ann. Clin. Biochem., 27, 21-24.
37. PAN, L. & GUTKOWSKA, J. (1988). Is clonidine-induced diuresis mediated by atrial natriuretic factor? Endocrinology, 123, 1259-1263.
38. PESONEN, A., LEPPALUOTO, J. & RUSKOAHO, H. (1990). Mechanism of opioid-induced atrial natriuretic factor release in conscious rats. J. Pharmacol. Exp. Ther., 254, 690-695.
39. RUSKOAHO, H. (1992). Atrial natriuretic peptide synthesis, release, and metabolism. [Review]. Pharmacol. Rev., 44, 479-602.
40. SCHILLER, P.W., NGUYEN, T.M.-D., CHUNG, N.N. & LEMIEUX, C. (1989). Dermorphin analogues carrying an increased positive net charge in their 'message' domain display extremely high muopioid receptor selectivity. J. Med. Chem., 32, 698-703.
41. SIMANTOV, R., KUHAR, J.J. UHL, G.R. & SNYDER, S.H. (1977). Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system. Proc. Natl. Acad. Sci. U.S.A., 74, 2167-2171.
42. STASCH, J. P., GROTE, H., KAZDA, S & HIRTH, C. (1989). Dynorphin stimulates the release of ANP from isolated rat atria. Eur. J. Pharmacol., 159, 101-102.
43. TANG, J., XIE, C.W., XIE, X.Z., GAO, X.M. & CHANG, J.K. (1987). Dynorphin A-(1-10) amide stimulates the release of atrial natriuretic polypeptide (ANP) from rat atrium. Eur. J. Pharmacol., 136, 449-450.
44. VOLLMAR, A.M., ARENDT, R.M. & SCHULZ, R. (1987). The effect of opioids on rat plasma atrial natriuretic peptide. Eur. J Pharmacol., 143, 315-321.
45. XIE, C.W., YIN, L.Y., XIE, X.Z., GAO, X.M., XIA, Z.Q., CHANG, J.K. & TANG, J. (1988). A dynorphin peptide induces hypotension by stimulating the release of atrial natriuretic peptide from rat atrium. Life Sci., 42, 1117-1122.
46. YAMADA, K., YOSHIDA, S. & SHIMADA, Y. (1991). Atrial natriuretic polypeptide secretion via selective activation of kappa-opioid receptor: role of dynorphin. Am. J Physiol., 261, E293-E297.